| Document |
Document Title |
|
WO/2024/152512A1 |
A lipid compound for delivery of a therapeutic agent, a preparation method therefor and a use thereof. The lipid compound is a compound having structural formula (I) or a pharmaceutically acceptable form thereof. The lipid compound may b...
|
|
WO/2024/152752A1 |
Disclosed in the present invention are a rasagiline mesylate oral thin film composition, and a preparation method therefor and a use thereof. The rasagiline mesylate oral thin film composition provided by the present invention comprises ...
|
|
WO/2024/152591A1 |
The present application relates to an organic compound and an electronic element and an electronic apparatus comprising same. The structural formula of the organic compound of the present application comprises structures represented by f...
|
|
WO/2024/151890A1 |
Embodiments of the present invention provide polar groups, linker compounds, linker drugs and conjugates thereof.
|
|
WO/2024/149776A1 |
The invention pertains to a process for purification of an aqueous brine solution comprising an amine comprising: - providing an aqueous brine solution comprising an amine, - contacting the aqueous brine solution with hydrogen chloride t...
|
|
WO/2024/147139A1 |
The invention provides 1,2-derivated phenylene compounds and composition comprising them and uses thereof in the method of treatment and prevention of diseases and conditions associated with or aggravated by impaired mitophagy or oxidati...
|
|
WO/2024/146905A1 |
A process for removing carbon dioxide from a liquid aqueous stream comprising at least one hexane-1,6-diamine species which comprises at least one carbon dioxide derivative of hexane-1,6-diamine, the process comprising providing the liqu...
|
|
WO/2024/138277A1 |
The present invention relates to compounds derived from 2-benzyloxyphenylethylamines of formula (I) and the pharmaceutically acceptable salts thereof. The invention also relates to the preparation of said compounds by means of a pathway ...
|
|
WO/2024/141842A1 |
The present invention provides ionic liquids of Formula (1) which have a wide electrochemical stability window (ESW).
|
|
WO/2024/142966A1 |
The problem addressed is: to provide a polymer mechanoradical initiator obtained by mechanochemical treatment of an organic polymer material as a radical initiator for reactions in which the polymer mechanoradical initiator component is ...
|
|
WO/2024/135134A1 |
The present invention further improves the selectivity of a hydride to be produced. Provided is a method for producing a hydride that comprises a step for bringing a compound having a double bond and/or a triple bond into contact with a ...
|
|
WO/2024/133048A1 |
The present invention relates to a method for preparing deuterated compounds and to deuterated compounds produced by the same method.
|
|
WO/2024/132698A1 |
The invention relates to a device for converting an oxygen-rich hydrocarbon feedstock derived from biomass, comprising: - a pyrolysis unit; - a reaction section for WGS gas to water conversion; - a fractionation train suitable for extrac...
|
|
WO/2024/124895A1 |
A synthesis method for a chiral phosphoric acid catalyst. A [1,1'-dinaphthalene]-2,2'-diol and a halogenating agent are used as raw materials, and are subjected to a halogenation reaction to obtain an intermediate I; an intermediate II a...
|
|
WO/2024/128515A1 |
The present invention relates to an antibacterial composition comprising a compound represented by chemical formula 1, the antibacterial composition having improved thermal stability and antibacterial activity.
|
|
WO/2024/124056A1 |
Methods of treating a stress-related disease or disorder such as PTSD and mood/depressive disorder, inducing neurite outgrowth, or inducing structural neuroplasticity, comprising administering to a subject a composition comprising an eff...
|
|
WO/2024/122345A1 |
The present invention addresses the problem of providing a method for producing a homo-coupling reaction product, whereby it becomes possible to substantially eliminate the use of an organic solvent, to carry out a reaction under a mild ...
|
|
WO/2024/122528A1 |
A method for producing a diamine containing a cyclohexane ring, the method comprising hydrogenating a diamine containing an aromatic ring in the presence of: a metal-containing alumina catalyst obtained by regeneration in catalyst regene...
|
|
WO/2024/122077A1 |
The present invention provides: a ceramic-loaded palladium catalyst which has excellent selective reduction properties and is applicable to flow synthesis; a method for producing this ceramic-loaded palladium catalyst; and a flow reactio...
|
|
WO/2024/121949A1 |
Provided are: a ceramic-carried palladium catalyst which has excellent selective reduction performance and which can be used in flow synthesis; a method for producing same; and a flow reaction device including the ceramic-carried palladi...
|
|
WO/2024/115263A1 |
A process for the manufacture of IPDA by hydrogenation of IPNI and/or IPN, comprising the steps of: a) feeding a stream comprising IPNI and/or IPN to a first hydrogenation reactor or a first series of hydrogenation reactors, b) feeding a...
|
|
WO/2024/114085A1 |
The present invention provides a triarylamine organic functional compound and a use thereof. The compound has a structure as represented by formula (I). The (A) group has a dibenzo five-membered ring or six-membered ring structure. The p...
|
|
WO/2024/110597A1 |
In a first aspect, the invention relates to a hydrogenation process for the hydrogenation of a compound comprising reacting the compound in a liquid medium with hydrogen in the presence of a heterogeneous hydrogenation catalyst in a reac...
|
|
WO/2024/110598A1 |
In a first aspect, the invention relates to a hydrogenation process for the conversion of a compound comprising reacting the compound in a liquid medium with hydrogen in the presence of a heterogeneous hydrogenation catalyst in a reactio...
|
|
WO/2024/108311A1 |
A method of assessing a risk of developing Alzheimer's disease (AD) and of diagnosing AD in a subject comprising: comparing a level of extracellular vesicles (EVs) that are positive for at least one biomarker in a biofluid sample taken f...
|
|
WO/2024/110339A1 |
The invention relates to a process for drying 1,5-diaminopentane, comprising the following steps: a) providing at least one substance mixture containing 1,5-diaminopentane and water; b) distilling the substance mixture in at least one di...
|
|
WO/2024/104472A1 |
Provided is a composition, comprising: a pyrene-based organic compound H as a host material, and a light-emitting body E having a narrow emission spectrum, wherein the organic compound H has high stability. The composition may contain an...
|
|
WO/2024/106024A1 |
The present invention provides a temperature-responsive ionic liquid that improves the permeability of various drugs in the skin, mucous membranes, etc. The present invention provides a temperature-responsive ionic liquid comprising an a...
|
|
WO/2024/104207A1 |
Provided are a spiro compound comprising an asymmetric alkyl substitution and an organic light-emitting device. The spiro compound has a structure represented by formula (1). The material has advantages such as high optical and electrica...
|
|
WO/2024/104473A1 |
Disclosed is a pyrene-based compound, having a structure as represented by chemical formula (I). The compound has a large molar extinction coefficient and fluorescence emission efficiency, and a color conversion layer made of the compoun...
|
|
WO/2024/098461A1 |
Provided are a polyalkyl p-phenylenediamine anti-aging agent having a structure as shown in formula I, and an intermediate thereof and a preparation method therefor. The polyalkyl p-phenylenediamine anti-aging agent has good thermo-oxida...
|
|
WO/2024/098460A1 |
A rubber anti-aging agent having a structure represented by formula A and a preparation method therefor. In formula A, R, Ra and Rb are as defined in the description. The rubber anti-aging agent can endow rubber with good thermo-oxidativ...
|
|
WO/2024/100533A1 |
A crystalline carbazole derivative, pharmaceutical compositions thereof, and methods of treatment are provided herein.
|
|
WO/2024/100405A1 |
The present invention relates to the field of catalytic hydrogenation and, more particularly, to methods of manganese-catalysed asymmetric hydrogenation of prochiral ketimine moieties to chiral amines.
|
|
WO/2024/093807A1 |
Disclosed is a method for preparing hexamethylenediamine, comprising the following steps: (1) under ammoniation reaction conditions, optionally in the presence of a solvent, causing hexanediol and ammonia to undergo an ammoniation reacti...
|
|
WO/2024/095734A1 |
This fluorine-containing heterocyclic compound production method is for obtaining a compound represented by formula (2) through intramolecular cyclization of a compound represented by formula (1). X1 represents a hydrogen atom, a fluorin...
|
|
WO/2024/094570A1 |
The present invention relates to a new process for preparing N,N´-dialkyl-p-phenylenediamine of the formula (I) and to the use of N,N´-dicyclohexyl-p-phenylenediamine at a purity of greater than 95.0% by weight as an anti-ageing agent ...
|
|
WO/2024/094156A1 |
Provided is a compound represented by formula (I), or a stereoisomer thereof, an optical isomer thereof, a solvate thereof, an isotope derivative thereof, or a pharmaceutically acceptable salt thereof. The compound can be used as a ligan...
|
|
WO/2024/093816A1 |
Disclosed is a method for preparing hexamethylenediamine. The method comprises the following steps: (1) under an ammoniation reaction condition, optionally in the presence of a first solvent, subjecting hexanediol and ammonia to an ammon...
|
|
WO/2024/090534A1 |
The present invention provides: a diamine or diamine composition in which, in a diamine obtained by depolymerization of a polyamide, there is little content of an aminoalcohol compound, which is a polymerization inhibiting component; and...
|
|
WO/2024/090919A1 |
The present invention provides an improved process for preparing a dimethyl-2,3-dihydro-1H-indene derivative or a pharmaceutically acceptable salt thereof. And, the present invention provides novel intermediates useful for the process. W...
|
|
WO/2024/091450A1 |
The present disclosure relates to compounds for treating cancer. The compounds may prevent conversion of non-stem cancer cells into cancer-initiating cells caused by radiation treatment.
|
|
WO/2024/089683A1 |
Anticancer conjugates combining a DNA methylation agent and an anticancer drug are provided herein, as well as uses of the same in cancer treatment.
|
|
WO/2024/087586A1 |
The present invention relates to an organic compound, an electronic element comprising same, and an electronic device. The structural formula of the organic compound is as shown in formula (1). The organic compound is used in an organic ...
|
|
WO/2024/090485A1 |
The present invention provides a method for producing a fluorine-containing compound under relatively mild conditions by introducing a fluorine atom into a wide variety of oxygen-containing compounds having a ketone group, an aldehyde gr...
|
|
WO/2024/085607A1 |
The present invention provides a novel compound and an organic light-emitting device using same.
|
|
WO/2024/085824A1 |
The invention relates to an agent which shows cytotoxic and anticancer properties and also anti-metastatic effects for prostate cancer cells, is suitable for use in the treatment of diseases caused by cancer cells or the prevention or el...
|
|
WO/2024/081857A1 |
A process for converting caprolactam to aminocapronitrile, the process comprising contacting a caprolactam feed with ammonia and an aluminosilicate zeolite catalyst to produce an aminocapronitrile product, wherein the catalyst comprises ...
|
|
WO/2024/081864A1 |
The invention relates to compounds and pharmaceutical compositions capable of treating and/or restoring or increasing sensitivity of NT5C2-mutant leukemia cells to chemotherapy, as well as methods of using thereof for treating and/or res...
|
|
WO/2024/075535A1 |
In the present invention, there is employed a resist composition having, as a base resin, a polymer compound that has constituent units derived from a compound expressed by general formula (a0−m). In the formula, W is a polymerizable-g...
|
